Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation Expense (2024 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Depreciation Expense for 2 consecutive years, with $81000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation Expense rose 6.58% to $81000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $329000.0, a N/A change, with the full-year FY2024 number at $308000.0, up 7.32% from a year prior.
  • Depreciation Expense was $81000.0 for Q3 2025 at Orchestra BioMed Holdings, roughly flat from $81000.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $84000.0 in Q4 2024 to a low of $74000.0 in Q1 2024.